NCT01562327 A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01475162 Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease Status TERMINATED Phase PHASE1/PHASE2
NCT01474291 An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice Status COMPLETED Phase N/A
NCT01468077 A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment Status COMPLETED Phase PHASE2
NCT01462162 A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01455701 A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) Status COMPLETED Phase PHASE1
NCT01441063 Tocilizumab for KSHV-Associated Multicentric Castleman Disease Status COMPLETED Phase PHASE2
NCT01362062 Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy Status COMPLETED Phase N/A
NCT01331837 A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Status COMPLETED Phase PHASE4
NCT01256736 To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01245452 Study of the Response and Cardiorespiratory Endurance in Early RA Patients Treated With Tocilizumab or Methotrexate Status COMPLETED Phase NA
NCT01211834 Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01209702 A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs Status TERMINATED Phase PHASE3
NCT01209689 A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy Status TERMINATED Phase PHASE3
NCT01163747 A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) Status COMPLETED Phase PHASE4
NCT01120366 Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation Status COMPLETED Phase PHASE4
NCT01119859 A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE4